0226 chmps
BioCentury & Getty Images

Regulation

Nod for Roche’s oral SMA drug among CHMP’s latest opinions: Data Byte

Feb 27, 2021 | 1:58 AM GMT

February’s recommendations by EMA’s CHMP included a nod in favor of Roche’s Evrysdi risdiplam, setting the drug

Read the full 400 word article

How to gain access

Continue reading with a
two-week free trial.